Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Sarcoma, Ewing 1 Pain 1 Osteosarcoma 1 Osteonecrosis 1 Nasopharyngeal Carcinoma 1 Motor Activity 1 Lymphoma, Non-Hodgkin 1 Lymphedema 1 Leukemia 1 Hodgkin Disease 1 Exostoses, Multiple Hereditary 1 Deglutition Disorders 1 Colonic Neoplasms 1 Chondrosarcoma 1 Breast Neoplasms 1 Bone Neoplasms 1 Anemia, Sickle Cell 1

Interventions

Iodine-131 14 trametinib 9 dabrafenib 9 Thyroidectomy 9 Surgical Procedures, Operative 9 lenvatinib 8 Thyroxine 8 Magnetic Resonance Spectroscopy 8 pembrolizumab 7 Paclitaxel 7 anlotinib 6 Thyrotropin Alfa 6 selpercatinib 5 Sorafenib 5 Saline Solution 5 Radiofrequency Ablation 5 Everolimus 5 pazopanib 4 Vemurafenib 4 Sunitinib 4 Radiotherapy 4 Nivolumab 4 Fluorodeoxyglucose F18 4 Dexmedetomidine 4 Cyclophosphamide 4 Biopsy, Fine-Needle 4 Biopsy 4 Bevacizumab 4 apatinib 3 Triiodothyronine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thyroid Neoplasms × Range of Motion, Articular × Clear all

NCT07623005 2026-06-03

PMRT-ThyCa

University of Faisalabad

Phase NA Completed

Pain, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡